camelid antibody-targeted oncolytic virus therapy (Washington University in St Louis)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namecamelid antibody-targeted oncolytic virus therapy (Washington University in St Louis)
Drug Alias NameN/A
ClassificationBiologics > Oncolytic virusBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashington University
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A